Prevalence of drug resistance mutations and their association with time to virological failure in people living with HIV in Uganda. [PDF]
Introduction Despite advancements in antiretroviral therapy (ART), virological failure and drug resistance mutations (DRMs) continue to pose major challenges, especially in resource-limited settings.
Ankunda C +6 more
europepmc +3 more sources
Prevalence and predictors of virological failure and quality of life of people with HIV/AIDS at a Municipal Hospital, Volta Region -Ghana: A cross-sectional study. [PDF]
BackgroundDespite several interventions to eradicate HIV/AIDS globally, virological failure continues to threaten the goals of antiretroviral therapies (ART) and quality of life (QoL) of people with HIV/AIDS (PWHA).
Peprah KG +4 more
europepmc +2 more sources
HIV vertical transmission linked to virological failure in pregnant women on ART. [PDF]
Minda Z, Oljira L.
europepmc +1 more source
Lived experiences of students with virological failure on antiretrovirals at a university in Limpopo. [PDF]
Maphakela MP, Kekana MP, Maimela E.
europepmc +1 more source
Virological failure in a pediatric cohort on a dolutegravir based regimen: a retrospective study in northwest Ethiopia, 2017-2023. [PDF]
Zewdu WS +5 more
europepmc +1 more source
Risk Factors Associated with Virological Failure in HIV Patients with Low Level Viremia: A Retrospective Study. [PDF]
Yang K +6 more
europepmc +1 more source
Virological failure and risk factors among people living with HIV taking second-line ART in Addis Ababa, Ethiopia. [PDF]
Feyissa BB +4 more
europepmc +1 more source
Behavioral Predictors of Intentional and Unintentional Nonadherence to Antiretroviral Therapy and Their Implications for Virological Failure Among People with HIV in Taiwan. [PDF]
Hsu SH +5 more
europepmc +1 more source
Field performance and cost-effectiveness of a point-of-care triage test for HIV virological failure in Southern Africa. [PDF]
Saura-Lázaro A +14 more
europepmc +1 more source
[Early virological failure with long-acting cabotegravir/rilpivirine: description of two cases]. [PDF]
Pena-López MJ +3 more
europepmc +1 more source

